Headquartered in San Diego, Innovus Pharma is an emerging leader in OTC and consumer products for men s and women s health and vitality. The Company generates revenues from its lead products Zestra for female arousal and EjectDelay for premature ejaculation and has a total of five marketed products in this space, including Sensum for the indication of reduced penile sensitivity, for sales outside the U.S. only , Zestra Glide, Vesele for promoting sexual and cognitive health, Androferti in the US and Canada to support overall male reproductive health and sperm quality and FlutiCare OTC for Allergic Rhinitis. Innovus Pharma s mission is to in license, acquire or develop over the counter and consumer healthcare products designed for in home treatment of medical conditions and ailments to help people take care of themselves and their families in order to live healthy lives.
Quote | InnovAge Holding Corp. (OTCMKTS:INNV)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $1.01 |
Close: | $1.01 |
High: | $1.0325 |
Low: | $1.01 |
Volume: | 21,885 |
Last Trade Date Time: | 02/12/2020 04:55:59 pm |
News | InnovAge Holding Corp. (OTCMKTS:INNV)
2024-06-10 08:19:41 ET More on InnovAge InnovAge Holding Corp. (INNV) Q3 2024 Earnings Call Transcript Read the full article on Seeking Alpha For further details see: InnovAge authorizes $5M share buyback program
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”) announced today that its Board of Directors has approved a share repurchase program (the “Program”) that authorizes the Company to repurchase up ...
Message Board Posts | InnovAge Holding Corp. (OTCMKTS:INNV)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $INNV News Article - InnovAge to Announce Fiscal Second Quarter 2023 Financial Results | whytestocks | investorshangout | 01/24/2023 9:10:47 PM |
whytestocks: $INNV News Article - InnovAge Announces Participation at the 41st Annual J.P. Morgan He | whytestocks | investorshangout | 01/05/2023 8:50:47 PM |
znewcar1: INNV 21% v1,14M c4.94 f135,5M H4.97 ML3.38 nice week pull. S@$4? | znewcar1 | investorshangout | 09/14/2022 10:17:35 PM |
whytestocks: $INNV News Article - InnovAge Announces Financial Results for the Fiscal Year and Fourt | whytestocks | investorshangout | 09/13/2022 8:10:46 PM |
whytestocks: $INNV News Article - InnovAge Appoints James Carlson to the Board as Non-Executive Chai | whytestocks | investorshangout | 06/30/2022 4:20:50 PM |
News, Short Squeeze, Breakout and More Instantly...
InnovAge Holding Corp. Company Name:
INNV Stock Symbol:
OTCMKTS Market:
InnovAge Holding Corp. Website:
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”) announced today that its Board of Directors has approved a share repurchase program (the “Program”) that authorizes the Company to repurchase up ...
DENVER, June 03, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE) has been recert...
ORLANDO, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), announce...